Triodos Investment Management Bv Edwards Lifesciences Corp Transaction History
Triodos Investment Management Bv
- $1.22 Billion
- Q3 2024
A detailed history of Triodos Investment Management Bv transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Triodos Investment Management Bv holds 509,258 shares of EW stock, worth $34.5 Million. This represents 2.74% of its overall portfolio holdings.
Number of Shares
509,258
Previous 407,958
24.83%
Holding current value
$34.5 Million
Previous $37.7 Million
10.82%
% of portfolio
2.74%
Previous 3.31%
Shares
24 transactions
Others Institutions Holding EW
# of Institutions
1,351Shares Held
455MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.24 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.45 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.14 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.78 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$916 Million0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $41.9B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...